Effects of Continuous Oral Intake of DR.ERGO(R) Ergothioneine Capsules on Skin Status: A Randomized, Double-Blind, Placebo-Controlled Trial
Abstract
Background: Ergothioneine (ergothioneine) is a naturally occurring antioxidant with emerging evidence supporting its role in cellular protection and anti-aging. However, clinical data on its cosmetic benefits remain limited. Objective: To evaluate the effects of daily oral supplementation with DR.ERGO(R) ergothioneine capsules on skin condition in healthy women reporting signs of skin aging. Methods: In this 8-week, randomized, double-blind, placebo-controlled trial, 66 women aged 35-59 years were assigned to receive either DR.ERGO(R) ergothioneine (30 mg/day) or placebo. Skin parameters including melanin index, erythema index, glossiness, elasticity (R2, R5, R7), spot count, wrinkle count were evaluated at baseline, 4 weeks, and 8 weeks. Results: Compared to placebo, the DR.ERGO(R) ergothioneine group showed significantly greater improvements in melanin and erythema reduction, skin glossiness, elasticity, and wrinkle and spot reduction (all p < 0.01). No adverse events were reported. Conclusion: Continuous oral intake of DR.ERGO(R) ergothioneine significantly improved skin aging parameters, with excellent safety and tolerability. These findings suggest DR.ERGO(R) ergothioneine may serve as an effective oral anti-aging agent.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Continuous oral intake of DR.ERGO(R) ergothioneine improves skin aging parameters in healthy women. The study addresses the cosmetic benefits of an antioxidant, which relates to the broader context of aging and skin health, although it primarily focuses on symptom management rather than addressing the root causes of aging.
Author of this paper? Send a correction.